D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$728M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$625M |
| 3 |
Merck
MRK
|
+$498M |
| 4 |
Bank of America
BAC
|
+$487M |
| 5 |
Fortinet
FTNT
|
+$321M |
Top Sells
| 1 |
Tesla
TSLA
|
+$696M |
| 2 |
Adobe
ADBE
|
+$610M |
| 3 |
Accenture
ACN
|
+$518M |
| 4 |
Microsoft
MSFT
|
+$495M |
| 5 |
Broadcom
AVGO
|
+$471M |
Sector Composition
| 1 | Technology | 22.95% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Healthcare | 10.4% |
| 4 | Financials | 9.83% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Progress Software
PRGS
$1.83B
| $18.7M | 0.02% |
277,446
+8,837
| +3% | +$595K |
|
602
American Airlines Group
AAL
$8.46B
| $18.7M | 0.02% |
1,661,386
+604,975
| +57% | +$6.8M |
|
603
Integra LifeSciences
IART
$1.2B
| $18.6M | 0.02% |
1,023,264
+167,912
| +20% | +$3.05M |
|
604
Constellium
CSTM
$2.02B
| $18.6M | 0.02% |
1,143,446
+799,473
| +232% | +$13M |
|
605
United Therapeutics
UTHR
$17.9B
| $18.5M | 0.02% |
51,550
+9,529
| +23% | +$3.41M |
|
606
Wabash National
WNC
$461M
| $18.4M | 0.02% |
960,314
+98,169
| +11% | +$1.88M |
|
|
XIFR
607
XPLR Infrastructure, LP
XIFR
$919M
| $18.4M | 0.02% |
664,799
-135,201
| -17% | -$3.73M |
|
608
Sotera Health
SHC
$4.47B
| $18.2M | 0.02% |
+1,090,084
| New | +$18.2M |
|
609
Xponential Fitness
XPOF
$294M
| $18.2M | 0.02% |
1,465,013
+100,000
| +7% | +$1.24M |
|
610
NetApp
NTAP
$24.7B
| $18.1M | 0.02% |
146,907
-147,198
| -50% | -$18.2M |
|
611
Pegasystems
PEGA
$9.66B
| $18.1M | 0.02% |
494,504
+88,164
| +22% | +$3.22M |
|
612
IDEAYA Biosciences
IDYA
$2.17B
| $18M | 0.02% |
567,731
-316,807
| -36% | -$10M |
|
613
American Eagle Outfitters
AEO
$3.34B
| $17.9M | 0.02% |
801,075
+613,027
| +326% | +$13.7M |
|
614
Pentair
PNR
$17.9B
| $17.9M | 0.02% |
182,980
+135,023
| +282% | +$13.2M |
|
615
Hims & Hers Health
HIMS
$10.8B
| $17.9M | 0.02% |
970,129
+512,589
| +112% | +$9.44M |
|
616
Compass Minerals
CMP
$752M
| $17.8M | 0.02% |
1,483,243
+152,665
| +11% | +$1.84M |
|
617
CRH
CRH
$74.7B
| $17.8M | 0.02% |
191,803
-389,555
| -67% | -$36.1M |
|
618
Kornit Digital
KRNT
$662M
| $17.8M | 0.02% |
687,340
-210,322
| -23% | -$5.43M |
|
619
Arch Capital
ACGL
$33.8B
| $17.7M | 0.02% |
158,405
-6,803
| -4% | -$761K |
|
620
MarketAxess Holdings
MKTX
$6.9B
| $17.7M | 0.02% |
69,090
+50,607
| +274% | +$13M |
|
621
RLI Corp
RLI
$6.08B
| $17.7M | 0.02% |
228,088
-95,672
| -30% | -$7.41M |
|
622
Halozyme
HALO
$8.87B
| $17.6M | 0.02% |
306,612
-172,163
| -36% | -$9.85M |
|
623
FedEx
FDX
$53.3B
| $17.5M | 0.02% |
64,103
-48,675
| -43% | -$13.3M |
|
624
DaVita
DVA
$9.46B
| $17.5M | 0.02% |
106,981
-40,062
| -27% | -$6.57M |
|
625
Fox Class B
FOX
$25.3B
| $17.5M | 0.02% |
451,364
-219,460
| -33% | -$8.52M |
|